Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024)

Xiaoyuan Xu1, Huiguo Ding2, Wengang Li3

  • 1Department of Gastroenterology, Peking University First Hospital, Beijing, China.

Insights

Updated clinical guidelines offer new recommendations for managing hepatic encephalopathy in cirrhosis. These guidelines cover diagnosis, treatment, and prevention strategies for patients with liver cirrhosis.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Clinical Medicine

Background:

  • Hepatic encephalopathy (HE) is a serious complication of cirrhosis.
  • Previous management guidelines for HE in cirrhosis were published in 2018.
  • Significant advancements in basic and clinical research necessitate guideline updates.

Purpose of the Study:

  • To revise and update the 2018 Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis.
  • To provide current evidence-based recommendations for HE management.
  • To consolidate expert consensus on diagnosis, treatment, and prevention.

Main Methods:

  • Convening a panel of experts from the Chinese Society of Hepatology.
  • Systematic review of recent global research on hepatic encephalopathy.
  • Consensus-building through expert discussions and Delphi methods.

Main Results:

  • The revised guidelines incorporate the latest research findings.
  • Recommendations address clinical diagnosis of HE in cirrhosis.
  • Updated strategies for primary and secondary prevention of HE are included.

Conclusions:

  • The updated guidelines provide a comprehensive framework for managing HE in cirrhosis.
  • These recommendations aim to improve patient outcomes and reduce HE recurrence.
  • The guidelines serve as a vital resource for clinicians managing cirrhosis patients.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
33
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
54
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
144
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
77
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
409